GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » 50-Day SMA

CSPC Pharmaceutical Group (FRA:CVG) 50-Day SMA : €0.73 (As of May. 11, 2024)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group 50-Day SMA?

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2024-05-11), CSPC Pharmaceutical Group's 50-Day SMA is €0.73. It's 20-Day SMA is €0.74 and 200-Day SMA is €0.72.


Competitive Comparison of CSPC Pharmaceutical Group's 50-Day SMA

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's 50-Day SMA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 50-Day SMA falls into.



CSPC Pharmaceutical Group  (FRA:CVG) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CSPC Pharmaceutical Group  (FRA:CVG) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


CSPC Pharmaceutical Group 50-Day SMA Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's 50-Day SMA provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (FRA:CVG) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (FRA:CVG) Headlines

From GuruFocus

A cheap dutch stock - Crown van Gelder

By batbeer2 batbeer2 01-09-2011

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2009

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010

WeissLaw LLP Investigates Convergys Corporation

By PRNewswire PRNewswire 06-30-2018

Convergys Corp. Reports Operating Results (10-K)

By gurufocus 10qk 02-25-2011

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010